ABEONA THERAPEUTICS INC. Other Noncash Income
ABEONA THERAPEUTICS INC. (ABEO) reported Other Noncash Income of $829.00 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncome · last filed 2019-08-09
- ABEONA THERAPEUTICS INC. other noncash income for the quarter ending 2019-06-30 was $660.00K.
- ABEONA THERAPEUTICS INC. other noncash income for the quarter ending 2019-03-31 was $169.00K.
- ABEONA THERAPEUTICS INC. other noncash income for the quarter ending 2018-06-30 was $0.00.
- ABEONA THERAPEUTICS INC. other noncash income for the quarter ending 2018-03-31 was $0.00.
- ABEONA THERAPEUTICS INC. other noncash income for fiscal 2018 was $626.00K.
- ABEONA THERAPEUTICS INC. other noncash income for fiscal 2017 was $0.00.
- ABEONA THERAPEUTICS INC. other noncash income for fiscal 2016 was $0.00.
| Period end | Other Noncash Income 3 month | Other Noncash Income 6 month | Other Noncash Income 12 month |
|---|---|---|---|
| 2019-06-30 | $660.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $829.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $169.00K 10-Q · filed 2019-05-10 | ||
| 2018-12-31 | $626.00K 10-K · filed 2019-03-18 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $0.00 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-10 | ||
| 2017-12-31 | $0.00 10-K · filed 2019-03-18 | ||
| 2016-12-31 | $0.00 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |